BridgeMD
New treatment option for Acute Brain Injury
Official title ECMO ABI Detection With Hyperfine
ClinicalTrials.gov ID: NCT06469801
What this study is testing
- What it's testing
- The primary objective is to characterize the prevalence and type of ABI following cannulation for pediatric patients who require ECMO support. The secondary objective is to describe the time course and rates of ABI using ultralow-field bedside MRI relative to both duration of ECMO support and clinical imaging obtained in routine care of pediatric ECMO patients.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 0 to 17
You may be able to join if
- Participants that will be or are admitted to the Pediatric Intensive Care Unit, Cardiac Intensive Care Unit, or the Neonatal Intensive Care Unit
- Ages 0-17 years
- Participants that are at high risk for undergoing ECMO or are currently undergoing venovenous or venoarterial ECMO
- High risk participants include, but are not limited to:
- Undergoing cardiac surgery
You likely can't join if
- Pregnancy
- Active implants such as:
- Pacemaker
- Implanted defibrillator
- Implanted insulin pump
- Deep brain stimulator
See the full eligibility criteria
- Participants that will be or are admitted to the Pediatric Intensive Care Unit, Cardiac Intensive Care Unit, or the Neonatal Intensive Care Unit
- Ages 0-17 years
- Participants that are at high risk for undergoing ECMO or are currently undergoing venovenous or venoarterial ECMO
- High risk participants include, but are not limited to:
- Undergoing cardiac surgery
- Congenital heart disease
- Congenital diaphragmatic hernia
- Refractory hypoxemic and/or hypercarbic respiratory failure
- Vasoactive-refractory shock
- Pregnancy
- Active implants such as:
- Pacemaker
- Implanted defibrillator
- Implanted insulin pump
- Deep brain stimulator
- Vagus nerve stimulator
- Cochlear implant
- Programmable shunt
- MRI incompatible surgical hardware (e.g., staples, screws, etc.)
- Metal-containing tattoos or permanent make-up on head or neck
- Suspected metal in eye, e.g.,
- Former or current welders, metal workers, or individuals with a metal injury
- Metal shrapnel
- Passive implants are considered MRI-conditional
The study team makes the final eligibility decision.
Where it's taking place
- Kansas City, Missouri, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 0 days to 17 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kansas City, Missouri, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.